GlassScriptPhysician profile
Michael David Nolte
NPI 1811370687
$1,400.51
in general payments reported to CMS, 2019-2025
13 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2021: $75.01 · 2022: $427 · 2023: $340 · 2024: $85.05 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $351.82 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Davol INC. | $180.70 | 2022-2024 | Arista Ah Flexitip |
| Medtronic, INC. | $165.32 | 2025 | Plasmablade(Tm) |
| Rti Surgical, INC | $140.54 | 2022 | |
| Sientra, INC. | $126.26 | 2022 | |
| Depuy Synthes Sales INC. | $123.17 | 2019 | |
| Medical Device Business Services, INC. | $110.94 | 2019 | |
| Innovation Technologies INC | $75.01 | 2021 | |
| Abbvie INC. | $36.45 | 2019-2023 | |
| Motiva USA, LLC | $31.42 | 2025 | |
| Organogenesis INC. | $23.37 | 2024 | |
| Integra Lifesciences Corporation | $19.37 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kci USA, INC. | $16.14 | 2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nolte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.